The following are new and competing renewal awards made to faculty in the Department of Pediatrics through the month of March 2020. Please extend your congratulations to the following individuals.
Pinar Gumus Balikcioglu, MD, MHS (Endocrinology) received an award from Diabetes Research Connection in the amount of $75,000 for a project entitled Branched Chain Amino Acids: Metabolomic Predictors of Skeletal Muscle Mass Accrual and Glycemic Control Among Children with Type 1 diabetes. The project period is 01/01/2020-12/31/2020.
Timothy Driscoll, MD (Blood and Marrow Transplantation) received an award from Astellas in the amount of $554,896 for a project entitled A Phase 2 Open-Label Non-Comparative, Multicenter Study to Evaluate the Safety and Tolerability Efficacy and Pharmacokinetics of Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis(IA) or Invasive Mucormycosis (IM) in Pediatric Subjects. The project period is 02/1/2020-12/31/2021.
Areeg El-Gharbawy, MBBCh, MD (Medical Genetics) received an award from Ultragenyx in the amount of $71,145 for a project entitled Anaplerotic Therapy Using Triheptanoin for Patients with Glycogen Storage Disease Type I. The project period 02/28/2020-02/23/2021.
Mai Elmallah, MBBCh (Pulmonary and Sleep Medicine) received an award from the National Institutes of Health/NINDS in the amount of $442,750 for a project entitled Respiratory Dysfunction in Optinearin Knock out L=ALS Mouse Model. The project period is 04/01/2020-09/30/02021.
Rachel Greenberg, MD (Neonatology) received an award from Children’s Hospital of Philadelphia in the amount of $54,570 for a project entitled Maternal and Neonatal Group B Streptococcus Seroepidemiol. The project period is 09/30/2019-09/29/2020/2020.
Christoph Hornik, MD, MPH (Critical Care Medicine) and Kanecia Zimmerman, MD, MPH (Critical Care Medicine) received an award from the National Institutes of Health/NICHD in the amount of $60,285 for a project entitled Pediatric Critical Care Research Landscape-a National Expert Conference. The project period is 04/01/2020-03/31/2021.
John Sleasman, MD (Allergy and Immunology; Pulmonary and Sleep Medicine) received an award from X4 Pharmaceuticals in the amount of $268,793 for a project entitled A Phase 3, Randomized Double Blind Placebo-Controlled Multicenter Study of Mavorixafor in Patients with WIHIM Syndrome with Open-Label Extension. The project period is 02/21/2020-11/30/2021.
Edward Smith, MD (Neurology) received an award from Avexis Inc., in the amount of $73,800 for a project entitled A Long-term Follow-up Study of Patients in the Clinical Trials for Spinal Muscular Atrophy Receiving AVXS-101. The project period is 02/27/2020-02/28/2035.
Congratulations to these faculty on their awards and best wishes to them in their investigative work.
Coleen K. Cunningham, MD
Vice Chair, Research
Professor of Pediatrics
Division of Infectious Diseases
Chief, Division of Global Health